<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mondal I</submitter><funding>Science and Engineering Research Board</funding><funding>Industrial Research and Development (IRD), IIT Delhi</funding><pagination>259</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11265472</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Glioblastoma (GBM) is the most aggressive among the tumors of the central nervous system (CNS), and has a dismal prognosis. Altered metabolism, especially the increased rate of aerobic glycolysis promotes rapid proliferation of GBM cells. Here, we investigated the role of aldehyde dehydrogenase 5 family member A1 (ALDH5A1), a mitochondrial enzyme in the aspect of GBM metabolism. We also studied the regulatory mechanisms of altered ALDH5A1 expression in GBM.&lt;h4>Approach and results&lt;/h4>We show that ALDH5A1 is significantly downregulated in GBM patients in a grade dependent manner as compared to control brain and its low expression is associated with poor prognosis. It is significantly downregulated under hypoxia and is a direct target of the hypoxia induced microRNA: miR-</pubmed_abstract><journal>Cancer cell international</journal><pubmed_title>ALDH5A1/miR-210 axis plays a key role in reprogramming cellular metabolism and has a significant correlation with glioblastoma patient survival.</pubmed_title><pmcid>PMC11265472</pmcid><funding_grant_id>MI02697G</funding_grant_id><funding_grant_id>CRG/2020/004640</funding_grant_id><pubmed_authors>Sarkar C</pubmed_authors><pubmed_authors>Mishra DP</pubmed_authors><pubmed_authors>Kulshreshtha R</pubmed_authors><pubmed_authors>Sharma V</pubmed_authors><pubmed_authors>Gupta N</pubmed_authors><pubmed_authors>Mondal I</pubmed_authors></additional><is_claimable>false</is_claimable><name>ALDH5A1/miR-210 axis plays a key role in reprogramming cellular metabolism and has a significant correlation with glioblastoma patient survival.</name><description>&lt;h4>Background&lt;/h4>Glioblastoma (GBM) is the most aggressive among the tumors of the central nervous system (CNS), and has a dismal prognosis. Altered metabolism, especially the increased rate of aerobic glycolysis promotes rapid proliferation of GBM cells. Here, we investigated the role of aldehyde dehydrogenase 5 family member A1 (ALDH5A1), a mitochondrial enzyme in the aspect of GBM metabolism. We also studied the regulatory mechanisms of altered ALDH5A1 expression in GBM.&lt;h4>Approach and results&lt;/h4>We show that ALDH5A1 is significantly downregulated in GBM patients in a grade dependent manner as compared to control brain and its low expression is associated with poor prognosis. It is significantly downregulated under hypoxia and is a direct target of the hypoxia induced microRNA: miR-</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-06-02T22:13:05.507Z</modification><creation>2025-04-19T13:10:38.87Z</creation></dates><accession>S-EPMC11265472</accession><cross_references><pubmed>39039535</pubmed><doi>10.1186/s12935-024-03432-z</doi></cross_references></HashMap>